SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.25 CNY | +4.88% |
|
+12.59% | +25.13% |
| 04-29 | Shanghai Shyndec Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
Evolution of the average Target Price on Shanghai Shyndec Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
5682367aed1a00dc96.ETzmEStKtcJ64JGpfTA2-IXZ5vXZ6WeRT49JKiar3Gw.S32xWBMbz6kzluDQPHV-vcStvqe-oiT4ee4RaB7ysA9lcopnGB_Xux2_-g~9f88954fb511deaf211c562c35a4f66a
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
12.25
Average target price
-
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 600420 Stock
- Consensus Shanghai Shyndec Pharmaceutical Co., Ltd.
